CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets esophageal cancer with Radiation-Activated nanoparticles
Disease control Recruiting nowThis early-phase study tests a new drug called NBTXR3, which is activated by radiation, along with standard chemotherapy for people with esophageal adenocarcinoma. The goal is to find the safest dose and see if this combination can better control the disease. About 24 adults with…
Matched conditions: CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:42 UTC
-
Could a common heart drug boost cancer treatment?
Disease control Recruiting nowThis study tests whether adding propranolol (a beta-blocker used for heart conditions) to standard chemotherapy and immunotherapy (pembrolizumab) can improve treatment response in people with advanced esophageal or gastroesophageal junction cancer that cannot be surgically remove…
Matched conditions: CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New combo before surgery aims to boost esophageal cancer outcomes
Disease control Recruiting nowThis study is for people with stage I to III esophageal or gastroesophageal junction cancer. It tests whether giving a shorter, higher-dose course of radiation along with the chemotherapy drugs FOLFOX before surgery can kill more tumor cells. The main goal is to see if this appro…
Matched conditions: CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Ear seeds may curb cancer appetite loss
Symptom relief Recruiting nowThis study tests whether a simple, non-invasive technique called auricular acupressure (using small pellets on the ear) can improve appetite and prevent weight loss in people with advanced stomach, esophageal, or pancreatic cancer. Researchers will enroll 66 patients to see if th…
Matched conditions: CLINICAL STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 01, 2026 15:38 UTC